# Early Dexmedetomidine and Sympathetic Regulation in Sepsis

> **NCT07470775** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Sichuan Academy of Medical Sciences** · enrollment: 168 (estimated)

## Conditions studied

- Sepsis
- Septic Shock

## Interventions

- **DRUG:** Dexmedetomidine (DEX)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07470775
- **Lead sponsor:** Sichuan Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07470775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07470775, "Early Dexmedetomidine and Sympathetic Regulation in Sepsis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07470775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*